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INTRODUCTION
 Inflammatory bowel disease (IBD) comprises of 
two associated but distinctive disorders: ulcerative 
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ABSTRACT
Objective: To determine different clinical presentations and disease location demarcated by upper and 
lower gastrointestinal endoscopy and relevant histopathology in children diagnosed with inflammatory 
bowel disease (IBD).
Methods: This is 5 years (2010 to 2015) retrospective study conducted at the Aga Khan University Hospital 
enrolling 65 admitted children between 6 months to 15 years from either gender, diagnosed with IBD 
on clinical presentation, endoscopy and biopsy. Different clinical presentations at the time of diagnosis 
were noted in different categories of the disease. All patients underwent upper and lower (up to the 
terminal ileum) endoscopy with multiple punch biopsies and histologic assessment of mucosal specimens. All 
endoscopies were done by paediatric gastroenterologists at endoscopy suite of the hospital and all specimens 
were reported by the pathology department. ESPGHAN revised criteria for the diagnosis of inflammatory 
bowel disease in children and an adolescent was used to standardize our diagnosis. Extent of disease on 
endoscopy and relevant histopathology of the biopsy samples were noted at the time of diagnosis. Data was 
summarized using mean, standard deviation, numbers and percentages for different variables.
Results: Total 56 children were enrolled according to inclusion criteria. There were 34 children (61.53%) 
diagnosed with ulcerative colitis (UC), 10 patients (16.92%) had Crohn’s Disease (CD) and 11 (21.53%) 
patients were labeled as Indeterminate colitis (IC). Mean age at onset of symptoms was10.03±2.44 and 
mean age at diagnosis was11.10±2.36. Abdominal pain (80%) and chronic diarrhea (70%) were common 
symptoms in CD whereas bloody diarrhea (79.41%) and rectal bleeding (64.70%) were common presentation 
in UC. Patients diagnosed with indeterminate colitis(IC) had similar clinical features as in UC patients. 
Only 7% patients had some extra-intestinal features in the form of joint pain and /or uveitis. Aspartate 
aminotransferase level (95.18 ±12.89) was relatively high in patients with CD in comparison with other 
categories of IBD. Endoscopic findings and relevant histopathology of biopsy samples in UC showed 65% 
patient had pan-colitis and 13% with disease restricted to rectum only whereas in CD 70% patient had 
disease in ileo-colon and only 10% had involvement of ileum at the time diagnosis.
Conclusion: Patients with UC dominated in our cohort. The most common clinical presentation in UC 
was bloody diarrhea and rectal bleeding and patients with CD had abdominal pain and chronic diarrhea 
as predominant clinical features. Extraintestinal features were uncommon in our cohort. In endoscopic 
findings, pan-colitis was the most frequent finding in UC and ileo-colon was common location in CD. IC and 
UC shared common clinical features and disease location on endoscopy.
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colitis (UC) and Crohn’s disease (CD). IBD is a 
disease of young people, with a peak incidence in 
the second and third decades of life. Approximately 
twenty-five percent of all cases usually present 
in childhood and adolescence.1 UC is a chronic, 
idiopathic, diffuse mucosal inflammatory disease 
of the colon whereas CD is a chronic, idiopathic, 
trans-mural and patchy, inflammation of one or 
more segments of the gastrointestinal tract; and the 
term indeterminate colitis (IC) is used for cases of 
colitis where pathologic findings are not adequate 
to differentiate between CD and UC.2,3
 Patients with Ulcerative Colitis usually presents 
with bloody diarrhea, abdominal pain and rectal 
bleeding. Crohn’s Disease patients predominantly 
presents with diarrhea and abdominal pain with 
increased tendencies to have systemic features like 
fever, fatigue, reduced appetite and weight loss. 
Upper and lower gastrointestinal endoscopy along 
with tissue biopsy for histopathology are crucial in 
making prompt diagnosis. Incidence of pediatric 
IBD varies in different countries, the highest being 
reported in Western countries especially in Northern 
parts of America and Europe.4 A growing tendency 
in the incidence and prevalence of inflammatory 
bowel disease (IBD) in Asia has been documented 
for the past two decades. It has been hypothesized 
that this phenomenon may be associated with the 
westernization of lifestyles, including changes in 
dietary practices and environmental changes such 
as improved hygiene and industrial development.5
 There is paucity of valid epidemiological studies 
on IBD from Asian countries and the results are 
variable. Limited data is available regarding south 
Asian children with IBD and mostly reported 
from immigrant population in West.6,7 This study 
highlights the different clinical presentations of 
children with IBD, their endoscopic location and 
related laboratory data.
METHODS
 A five years retrospective study was conducted at 
Aga Khan University Hospital from January 2010 to 
December 2015 after approval from Ethical review 
committee of the institution. Patients diagnosed 
with inflammatory bowel disease (IBD) on the basis 
of clinical history, physical examination, endoscopic 
and histopathology findings from age 6 months to 
15 years from either gender were enrolled in this 
study. Different clinical presentations (including 
intestinal and extra-intestinal) at the time of 
diagnosis were noted in different categories of the 
disease.
 Patients were categorized into three groups 
depending on the type of pathology seen on biopsy 
and endoscopy. All patients underwent upper and 
lower (up to the terminal ileum) endoscopy with 
multiple punch biopsies and histologic assessment 
of mucosal specimens. All Endoscopies were done 
by paediatric gastroenterologist at Endoscopy 
suite, the Aga Khan University Hospital and all 
specimens were reported by Pathology department 
of the hospital. ESPGHAN revised criteria for 
the diagnosis of inflammatory bowel disease in 
children and an adolescent was used to standardize 
our diagnosis.8
 Ulcerative Colitis (UC) was defined by the 
occurrence of continuous inflammation limited 
to the colon with histologically typical chronic 
inflammation limited to the mucosa. The most 
dependable feature to diagnose UC is continuous 
mucosal inflammation of the colon, beginning from 
the rectum, without small bowel involvement, 
and without granulomas on biopsy. Characteristic 
macroscopic features of UC include erythema, 
friability, granularity, purulent exudates, and ulcers 
that usually look as superficial small ulcers. 
 Crohn’s Disease (CD) was defined by evidence 
of a skipped, non-contiguous chronic inflammation 
of the gastrointestinal tract with or without 
granulomas and reinforced by clinical, histologic 
and endoscopic evidence. These key features include 
the occurrence of skip lesions; the presence of well-
formed non-caseating granulomas distant from 
ruptured crypts any place in the gut; the existence 
of macroscopic lesions of the upper intestinal tract, 
in specific serpentine ulcers and cobble stoning, 
stenosis or structuring of bowel.
 Indeterminate Colitis (IC) was defined as inflam-
matory colitis having uncertain endoscopic and his-
tologic findings making differentiation between UC 
and CD difficult even after a complete workup. In 
addition, such patients did not show any evidence 
of small bowel disease at the time of diagnosis.
 Complete blood count, CRP, albumin and serum 
Alanine aminotransferase level of these enrolled 
patients were documented. Extent of disease on 
endoscopy was noted at the time of diagnosis. 
Radiological evidence in the form of barium studies 
were collected but it was found that most of the 
patients did not undergo radiological examination. 
Results were analyzed using SPSS version 20. Data 
was summarized using mean, standard deviation, 
numbers and percentages for different variables 
including sex, age, clinical features and laboratory 
and endoscopic findings.
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RESULTS
 Total 55 children were enrolled as cases with IBD 
on the basis of defined criteria. Mean age at onset of 
disease was 10.03±2.44 and mean age at diagnosis 
was 11.10±2.36. Thirty nine patients (65%) patient 
had UC, 10 (16%) patients diagnosed with CD and 
16 (21.21%) patients had IC (Table-I). The most 
common gastrointestinal symptom common in 
Ulcerative colitis was bloody diarrhea and the most 
frequent complaints in CD were abdominal pain and 
chronic diarrhea. No hepatobiliary complications 
were noted in our study. Only 7% patients had 
some extra-intestinal features in the form of joint 
pain and /or uveitis (Fig.1). Table-II shows disease 
locations in different categories of IBD.
DISCUSSION
 Inflammatory bowel disease is rare pathology in 
pediatric age group and somewhat underdiagnosed 
entity in our region.9,10 Pediatric IBD is separate 
entity in its presentation, location of disease and 
response to treatment. In our cohort male to female 
ratio was 1.3:1 which is quite similar to the reported 
studies in pediatric age group. In pediatric CD 
there is a strong tendency toward males.11 Vernier-
Massouille et al also confirmed male predominance, 
with a similar ratio of 1.4:1 in children younger 
than 15 years.12 Frequencies of different types of 
IBD vary with age, location and demography of 
population. Most studies report a predominance of 
CD incidence in children and adolescent over UC, 
although some evidence shows contrary picture.13 
Certain studies proclaimed that the incidence of CD 
is increasing, particularly in young children, while 
the UC incidence remains constant.11 Van Limburger 
et al demonstrated a significant predilection for 
CD in children14 whereas some studies showed 
predominance of UC in pediatric age group.15,16 
Generally UC is found to be more frequent than CD 
in the preschool age group, whilst CD is three times 
more frequent than UC in older children in many 
case series.17
 Our study is unique in reporting strong predilec-
tion towards UC followed by IC. The low frequency 
of CD is partly due to overlapping symptoms with 
intestinal tuberculosis which mimics with CD in 
clinical presentation and disease location on endos-
copy.18 Intestinal tuberculosis usually presents with 
Paediatric Inflammatory Bowel Disease
Table-I: Demographic Features.
 Ulcerative colitis  Crohn’s Disease  Indeterminate Colitis  Total
 34 (61.81%) 10 (18.18%) 11 (20.00%)
Male 21(38.18%) 6 (10.90%) 7(12.72%) 34 (61.81%)
Female 13(23.63%) 4(7.27%) 4(7.27%) 21(38.18%)
M: F ratio 1.6 : 1 1.5 : 1 1.7 : 1 1.6 : 1
Median age at onset 10.41 ± 2.61 9.10 ± 1.66 9.72 ± 2.41 10.03±2.44
Median age at diagnosis 11.11 ± 2.47 11.40 ±2.45 10.81 ± 2.08 11.10±2.36
Family History 2 (3.63%) 1(1.81%) 0 3 (5.45%)
Fig.1: Clinical Presentations.
Table-II: Laboratory Investigations and Mean values with Standard deviation.
Investigations Ulcerative Colitis Crohn’s Disease Indeterminate Colitis
Hemoglobin (g/dl) 8.99 ± 1.90 8.53 ± 2.21 9.90 ±2.55
Total leukocyte count (X 10E9/L) 12.35 ±6.30 13.86 ± 5.53 12.40 ± 4.44
Platelet count (X 10E9/L) 220.97 ± 94.48 372.90 ± 166.29 190.09 ± 46.62
C-reactive protein (CRP) mg/dl 2.77 ± 4.62 5.82±6.40 3.23 ± 3.74
Serum Albumin (g/dl) 3.12 ± 1.4 2.98 ± 1.73 3.52 ± 1.81
Alanine aminotransferase (ALT/SGPT) IU/L 34 ± 7.63 95.18 ±12.89 45.90 ± 7.07
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an unremitting pattern of ulcers in the colon and 
small bowel, most characteristically in the ileo-cecal 
area which is also the most common site for Crohn’s 
disease.18 This also results in late diagnosis in pa-
tients with CD as seen in our experience with aver-
age delay of two years between onset of symptoms 
and diagnosis. Clinical presentation correlates with 
the disease location. Abdominal pain with chronic 
diarrhea was the most common clinical feature in 
CD whereas bloody diarrhea, rectal bleeding and 
abdominal pain were common in UC which are 
similar to multiple experiences round the globe.7,19 
IC showed similar clinical features to UC in our 
cohort. Three patients had perianal disease in our 
series. Pediatric CD mostly behaves with inflamma-
tory or non-stricturing, non-penetrating disease.20
 In this study only one patient had stricturing 
disease and one patient presented with penetrating 
disease. In our cohort, weight loss followed by fever 
and pallor were common in patients with CD as 
compared to UC. Poor growth prior to diagnosis 
has been documented in many studies examining 
growth in pediatric IBD.21 Extra-intestinal 
manifestations are reported less frequent in our 
cohort as in seen in many adults’ IBD series in our 
region.19 In general, extra-intestinal manifestations 
were more common in Crohn’s disease. Location 
of the pathology seen on endoscopy is a crucial 
aspect in diagnosing and characterizing IBD which 
defines the management and prognosis of the 
disease. Disease location at presentation varies in 
pediatric IBD related with adult IBD.22 Paediatric 
UC frequently presents with aggressive phenotype 
with pancolitis and early time to first surgery 
compared to adult UC.20,23
 In UC the inflammation may either finish at a 
transition zone anywhere in the colon or include 
the entire colon continuously. The most distal part 
of the terminal ileum may demonstrate non-erosive 
erythema or edema if there is pancolitis (‘‘backwash 
ileitis’’).8 In our cohort patients with UC, almost 
65% patients had disease involving entire colon. 
Disease restricted to rectum was seen only in 13% 
patients with UC. These findings are quite similar 
to Sawczenko A et al.23 Patients with CD showed 
most of the patients had presences of disease at 
ileocolonic area similar to Auvin et al.20 Only one 
patient had terminal ileal disease. In group with IC, 
50% patient had involvement of entire colon. In our 
experience UC and IC had many similarities in the 
way of clinical presentation and disease location.
CONCLUSION
 Patients with UC dominated in our cohort fol-
lowed by IC. Frequency of CD was very low in our 
experience. There is average delay of one year from 
onset of symptoms and diagnosis including all sub-
types of IBD. The most common clinical presenta-
tion in UC was bloody diarrhea and rectal bleed-
ing and patients with CD had abdominal pain and 
chronic diarrhea as predominant clinical features. 
Extraintestinal features were uncommon in our 
cohort. In endoscopic findings, pan-cloitis was the 
most frequent finding in UC and ileo-colon was 
common location in CD. IC and UC shared common 
clinical features and disease location on endoscopy.
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